SCHEMBL23605175

SCHEMBL23605175

CCOC1(c2ccc(C(=O)N3CCCC(c4ccc(C(F)(F)F)cc4)C3)cc2)COC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PROKR1 Q8TCW9 8/20 0.51
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ SCN9A Q15858 1/20 0.44
▸ PDE2A O00408 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RAB9A P51151 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ PKM P14618 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ADRB2 P07550 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577481 1.00 PROKR1 (0.51) PROKR1ALDH1A1HPGDLMNAHIF1A
SCHEMBL23605683 0.90 PROKR1 (0.53) PROKR1ALDH1A1HPGDLMNAHIF1A
SCHEMBL23577508 0.90 GAA (0.46) HPGDMEN1KMT2ATSHRTDP1
SCHEMBL23605482 0.84 PROKR1 (0.54) PROKR1ALDH1A1HPGDLMNAHIF1A
SCHEMBL23605575 0.80 LIPE (0.37) PROKR1
SCHEMBL23577479 0.80 GAA (0.43) HPGDLMNAMEN1KMT2ATSHR
SCHEMBL23577488 0.80 EGLN1 (0.47) HPGDMEN1KMT2ATSHRTDP1
SCHEMBL23577764 0.80 GAA (0.45) HPGDMEN1KMT2ATSHRTDP1
SCHEMBL23577378 0.80 GAA (0.45) HPGDMEN1KMT2ATSHRTDP1
SCHEMBL30045969 0.80 EPHX2 (0.40) HPGDMEN1KMT2ATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP claimed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN claimed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN disclosed
WO-2021130723-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA CADILA HEALTHCARE LIMITED (IN) 2021-07-01 — — WO disclosed
Send feedback